Trials / Unknown
UnknownNCT04927130
Retrospective Comparative in Vitro Case-controlled Study of the Liquid Biopsy Test System in Women With Breast Cancer
An International Multicenter Blind Retrospective Comparative in Vitro Case-controlled Study of the ARNA Breast Liquid Biopsy Test System in Women With Biopsy Confirmed Breast Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- ARNA Genomics US Inc. · Industry
- Sex
- Female
- Age
- 35 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Proof of Concept retrospective study. Women who have the diagnosis Breast Cancer ( confirmed by biopsy) will donate a blood samples. Tubes with blood will be transferred to the Sponsors Laboratory and ARNA Breast Test will be performed. The result of test will be compared with the biopsy result for each person.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | ARNA Breast | A specific DNA fragments and globulins will be detected in blood plasma. |
Timeline
- Start date
- 2021-06-16
- Primary completion
- 2021-10-29
- Completion
- 2021-12-31
- First posted
- 2021-06-15
- Last updated
- 2021-06-25
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT04927130. Inclusion in this directory is not an endorsement.